cover
Contact Name
Ratna Kumalasari
Contact Email
medicinus@dexagroup.com
Phone
+6287808191388
Journal Mail Official
medicinus@dexagroup.com
Editorial Address
Gedung Titan Center 5th Floor, Jl. Boulevard Bintaro B7/B1 No. 5, Bintaro Jaya Sektor 7, Pokdok Aren, Tangerang Selatan 15224
Location
Kota tangerang selatan,
Banten
INDONESIA
MEDICINUS
Published by PT Dexa Medica
ISSN : 1979391X     EISSN : 29638399     DOI : 10.56951
Core Subject : Health, Science,
Tujuan penerbitan jurnal Medicinus adalah untuk meningkatkan wawasan dan menambah khasanah pengetahuan para praktisi medis dan farmasis di bidang kedokteran dan kefarmasian. Ruang lingkup dari jurnal ilmiah ini adalah publikasi artikel-artikel ilmiah yang bisa disajikan dalam bentuk penelitian (research), laporan kasus (case report), teknologi dan klinis kefarmasian, serta ulasan literatur medis.
Articles 254 Documents
Profil Hematologi Pasien Hipertiroid yang Mendapatkan Terapi Obat Antitiroid di Poliklinik Endokrin, Metabolik, dan Diabetes RSUP Prof. dr. I.G.N.G. Ngoerah, Denpasar Tahun 2023 Made Aryadi Sukartika; Made Ratna Saraswati
MEDICINUS Vol. 39 No. 8 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/a3q99673

Abstract

Introduction: Antithyroid drugs are one of the treatment options for hyperthyroidism, alongside surgery and radioactive iodine treatment. The antithyroid medications used are thiocarbamide/thiocyanate derivatives, such as propylthiouracil (PTU) and methimazole. Information on the characteristics of hyperthyroid patients, especially regarding possible hematological adverse effects such as agranulocytosis, thrombocytopenia, and pancytopenia, can assist physicians in considering treatment options. Methods: This descriptive, retrospective study used medical records to describe the hematological profile of hyperthyroid patients receiving antithyroid medication therapy at the Endocrine, Metabolic, and Diabetes Polyclinic of RSUP Prof. dr. I.G.N.G. Ngoerah, Denpasar, Bali in 2023. Results: A total of 261 patients were included. The most common age range was 51–60 years (64 patients, 24.5%), and the majority were female (78.5%). The duration since hyperthyroidism diagnosis was most often <12 months (129 patients, 49.4%). The most frequent diagnosis was suspected Graves’ disease (187 patients, 71.6%), and most patients (210, 80.5%) had no comorbidity. In the methimazole group (218 patients, 83.5%), no patient (0%) developed agranulocytosis, 70 (32.1%) had hemoglobin <12 g/dl, and 14 (6.4%) had platelets <150 ×10³/μl. In the propylthiouracil group (43 patients, 16.5%), 1 patient (2.3%) developed agranulocytosis, 18 (41.9%) had hemoglobin <12 g/dl, and 3 (7%) had platelets <150 ×10³/μl. Discussion: The low occurrence of agranulocytosis (0% with methimazole and 2.3% with propylthiouracil) indicates that antithyroid drug-induced hematologic abnormalities are very rare, consistent with the reported figure of 0.2–0.5% in patients with Graves’ disease. Differences between groups may be influenced by study population characteristics, genetic factors, duration of drug use, and the unequal proportion of the two treatment groups. Conclusions: Hematologic abnormalities among hyperthyroid patients receiving antithyroid drugs were low and tended to be more frequent in the propylthiouracil group. Normal neutrophil counts were found in 191 patients (87.6%) of the methimazole group and 39 patients (90.7%) of the propylthiouracil group.
The Association Between Knee Osteoarthritis Risk Factors and Quality of Life Among Patients with Knee Osteoarthritis in Ubung Village I Gusti Agung Bagus Arya Wiradarma; Gede Kambayana; Pande Ketut Kurniari; Dewa Ayu Kartika Tejawati; Sandra Surya Rini
MEDICINUS Vol. 39 No. 8 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/257rnt42

Abstract

Osteoarthritis is a degenerative joint disease that affects the synovial membrane, cartilage, ligaments, and bones. Several risk factors for osteoarthritis include increasing age, family history of generalized osteoarthritis, heavy physical activity, obesity, and previous joint trauma or deformity. This study aimed to identify the knee osteoarthritis risk factors associated with patients’ quality of life. A cross-sectional study was conducted among 91 patients with knee osteoarthritis in Ubung Village, Denpasar City. Data were collected using the Short Form-36 (SF-36) questionnaire to assess the quality of life of the patients. Body weight was measured using a weighing scale, and height was measured using a stadiometer to determine body mass index (BMI). The results showed that several factors were significantly associated with poor quality of life among patients with knee osteoarthritis in Ubung Village, including age >60 years (odds ratio [OR]=4.331), female sex (OR=5.571), excess body weight (OR=7.353), and vigorous physical activity (OR=3.368). Overall, 73.6% of patients demonstrated a good quality of life. However, domain-specific analysis revealed moderate to low median scores in several components, including work limitations due to physical health disorders, pain, and general health. Bivariate analysis furtherdemonstrated that age >60 years, female sex, overweight or obesity status (BMI >23 kg/m²), occupations involving heavy physical activity, and a history of knee trauma were significantly associated with poor quality of life.
Low Serum Zinc Levels as a Risk Factor for Tuberculosis Coinfection in Patients with Human Immunodeficiency Virus Rionaldo Anthonius de Quelyoe Junior; Anak Agung Ayu Yuli Gayatri; I Ketut Agus Somia
MEDICINUS Vol. 39 No. 8 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/7rejg862

Abstract

Background: Tuberculosis (TB) remains the leading opportunistic infection and cause of mortality among people living with human immunodeficiency virus (HIV). Micronutrient deficiencies, particularly zinc deficiency, have been implicated in immune dysfunction and increased susceptibili.ty to TB. However, data regarding the role of serum zinc levels in HIVTB coinfection in Indonesia remain limited. Objective: To evaluate low serum zinc levels as a risk factor for tuberculosis infection among HIV-infected patients. Methods: This was a nested case-control study conducted at RSUP Prof. dr. I.G.N.G. Ngoerah, Denpasar, Bali, Indonesia, between May and October 2024. A total of 60 adult HIV patients wereenrolled, consisting of 30 HIV-TB coinfected patients (cases) and 30 HIV patients without TB (controls), matched by age and sex. Serum zinc levels were measured using inductively coupled plasma-mass spectrometry (ICP-MS). Tuberculosisdiagnosis was established using the GeneXpert MTB/RIF molecular assay. Bivariate and multivariate logistic regression analyses were performed to identify independent risk factors for TB coinfection. Results: Low serum zinc levels(<70 mcg/dl) were significantly more frequent among HIV-TB patients compared to controls (76.7% vs. 30.0%). Multivariate logistic regression showed that zinc deficiency was independently associated with TB coinfection (adjusted odds ratio [aOR] 5.56; 95% confidence interval [CI] 1.431–21.590; p=0.013). Other variables, including lack of isoniazid (INH) preventive therapy and CD4 count <200 cells/μl (aOR 2.64; 95% CI 0.54–12.98; p=0.223), were not independently associated with TB coinfection. Conclusion: Low serum zinc levels are an independent clinical risk factor for tuberculosisamong patients with HIV. Assessment of zinc status may help identify HIV-infected individuals at higher risk for TB and support targeted preventive strategies.
Faktor Risiko Osteoartritis Lutut dan Kualitas Hidup Pasien: Dari Kerusakan Sendi Menuju Beban Hidup Sehari-hari Raymond R. Tjandrawinata
MEDICINUS Vol. 39 No. 8 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/z1jkd695

Abstract

Knee osteoarthritis is a whole-joint disease leading not only to structural damage but also to pain, functional limitations, impaired daily activities, and reduced quality of life. This article discusses the association between various major risk factors for knee osteoarthritis, including advanced age, obesity, female sex, history of knee injury, repetitive mechanical loading, muscle weakness, joint malalignment, and metabolic comorbidities, with patients’ quality of life. The severity of radiographic findings in knee osteoarthritis does not always correlate with the intensity of pain or functional limitations experienced by patients. Therefore, assessment and management should be oriented toward improving patients’ function and quality of life through education, physical exercise, weight management, rational pharmacological treatment, and selective intraarticular interventions. Treatment success should ultimately be evaluated based on its ability to improve patients’ mobility, independence, and social participation.
Korelasi antara Aliran Arteri Brakialis dan Fraksi Ejeksi pada Pasien Hemodialisis Reguler dengan Aneurisma Fistula Arteriovenosa I Gusti Agung Ayu Indrayuni
MEDICINUS Vol. 39 No. 9 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/7knqs723

Abstract

Patients with end-stage chronic kidney disease (CKD) generally depend on hemodialysis, with arteriovenous fistula (AVF) being the preferred vascular access due to its lower risk of complications. Long-term use of AVF may lead to aneurysm formation, which potentially alters hemodynamics and increases cardiac workload. Elevated brachial artery flow (BAF) in patients with AVF aneurysms may affect cardiac function, particularly left ventricular ejection fraction (EF). A cross-sectional study was conducted in nine patients undergoing routine hemodialysis with AVF aneurysms at RSUP Prof. dr. I.G.N.G. Ngoerah, Denpasar, Bali. BAF was measured using Doppler ultrasonography and EF was assessed by transthoracic echocardiography. The association between BAF and EF was analyzed using Pearson correlation and simple linear regression. The mean BAF was 1,149.16 ± 1,816.97 ml/minute, and the mean EF was 48.04 ± 15.74%. The results revealed a weak negative correlation between BAF and EF (r=-0.346, p=0.361). Linear regression analysis showed that each 1 ml/minute increase in BAF was associated with a 0.003% decrease in EF. However, the result was not statistically significant. Further studies with larger sample sizes are needed to investigate the association between BAF and EF.
Tumefactive Relapsing-Remitting Multiple Sclerosis in A 42-Year-Old Male: A Case Report Rocksy Fransisca V. Situmeang; Nadia Gabriella
MEDICINUS Vol. 39 No. 9 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/yc31g757

Abstract

Background: Tumefactive multiple sclerosis (TMS) is a rare variant of multiple sclerosis (MS) characterized by acute, tumor-like demyelinating lesions in the central nervous system (CNS). This feature can closely mimic intracranial space-occupying lesions, including CNS neoplasms and abscesses, thereby posing significant diagnostic challenges. We report a case of TMS in a 42-year-old male. Case presentation: A 42-year-old male presented with an 8-month history of relapsing and remitting neurological deficits, including tetraparesis, sensory disturbances, impaired consciousness, facial (CN VII) and hypoglossal (CN XII) nerve palsies, and nonfluent aphasia. Cerebrospinal fluid analysis revealed elevated protein levels and inflammatory markers, including interleukin (IL)-6, IL 10, soluble IL-2 receptor (sIL-2R), with negative anti-aquaporin-4 (AQP4) and antimyelin oligodendrocyte glycoprotein (MOG). Initial brain magnetic resonance imaging (MRI) revealed multiple contrast-enhancing white matter lesions with incomplete ring enhancement. Although his symptoms improved following treatment with high-dose intravenous (IV) methylprednisolone, his symptoms subsequently relapse. Repeat MRI showed regression of most lesions, and a new spinal lesion at the C2–C4 level. He was diagnosed with tumefactive relapsing-remitting multiple sclerosis (RRMS) and received another course of high-dose IV methylprednisolone, followed by the initiation of mycophenolate mofetil therapy. Conclusions: This case highlights the importance of considering TMS in the differential diagnosis of patients presenting with large, contrast enhancing brain lesions, even when clinical features are not typical of multiple sclerosis.
Multiorgan Involvement in Severe Plasmodium Falciparum Malaria: A Case Report of Hepatopathy and Acute Kidney Injury Rionaldo Anthonius; Ni Made Dewi Dian Sukmawati
MEDICINUS Vol. 39 No. 9 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/ywp9an33

Abstract

Malaria remains a significant cause of mortality worldwide. Severe malaria can manifest with organ dysfunction, including acute liver and kidney injury. A 46-year-old man presented with a 21-day history of high-grade fever, chills, and jaundice following travel to Jayapura, Papua. Physical examination revealed icteric sclera, hepatomegaly (15 cm), and splenomegaly (Schuffner grade 2). Laboratory investigations confirmed Plasmodium falciparum infection, with a parasite density of 31,920 parasites/μl, severe hyperbilirubinemia (total bilirubin 13 mg/dl), elevated transaminase levels, and acute kidney injury. The patient was treated with intravenous artesunate (2.4 mg/kg) at 0, 12, and 24 hours, followed by daily doses of oral artemisinin-based combination therapy. Parasite clearance was achieved within 48 hours, with clinical recovery and improvement in hepatic and renal function by day 7. Early recognition of a relevant travel history is essential for the prompt diagnosis and management of severe malaria and its complications.
Pengembangan Tablet Isap Imunostimulan yang Mengandung Kombinasi Ekstrak Buah Ciplukan (Physalis angulata L.) dan Ekstrak Propolis Shofwan Alkami; Liana Oktaviani Nur Izmi; Wildan Hidayatullah; Heni Rachmawati
MEDICINUS Vol. 39 No. 9 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/wd0g4063

Abstract

Background:  Physalis angulata L. fruit (ciplukan) is rich in immunostimulatory compounds but exhibits poor water solubility. To enhance its efficacy, particle size reduction into microparticle extract (ekstrak mikropartikel buah ciplukan/EMC) combined with propolis in a lozenge formulation was developed. Objective: This study aimed to characterize EMC, evaluate its safety in vitro and in vivo in Wistar rats, and formulate and assess the immunostimulatory activity of the combination lozenges. Methods: EMC was characterized using scanning electron microscopy (SEM), particle size analyzer (PSA), and phytochemical screening. In vitro safety was evaluated using RAW 264.7 cell line. In vivo safety evaluation included organ index, hematological parameters, splenic histology (white pulp diameter), and hepatic mannose receptor (CD206) expression. Lozenges containing a combination of EMC, propolis, vitamin C, vitamin D, and zinc (Zn) were formulated and evaluated for its immunostimulatory activity in vivo. Results: EMC exhibited a spherical morphology and was rich in phenolic compounds, flavonoids, and alkaloids. RAW 264.7 cell viability remained >100% up to a concentration of 500 ppm, indicating the absence of cytotoxic effects. In vivo, EMC at a dose of 37.8 mg/kg body weight/BW (equivalent to human dosage of 300 mg EMC/70 kg BW) significantly increased white blood cell profiles (leukocytes, lymphocytes, monocytes, and granulocytes), splenic white pulp diameter (reaching 531.81 μm), and hepatic CD206 expression (reaching 25.721%) compared to the negative control and gallic acid comparator groups (p<0.05). The combined lozenge formulation containing both extracts also significantly enhanced all evaluated immunological parameters compared to the negative control (p<0.05). Conclusion: The combined EMC and propolis extract lozenge formulation shows potential for further development as an alternative formulation to support the body’s defense system.
Modalitas Terapi Cairan Pada Pasien  Acute Kidney Injury dan Critical Illness: A Narrative review  Morris Lintong Barimbing; Nyoman Paramita Ayu
MEDICINUS Vol. 39 No. 9 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/q0a7pn86

Abstract

Fluid management is one of the main modalities in the management of critically ill patients and those with acute kidney injury (AKI). Fluid management in critically ill patients is both a simple and complex process, because fluid therapy can be a double-edged sword; where both inadequate and excessive administration may aggravate target organ injury. Assessment of the patient’s volume status is a key factor in determining fluid replacement strategies in critically ill patients with AKI. The type and rate of fluid replacement have consequences for clinical outcomes, including the development of AKI and the risk of AKI progression. Both hypovolemia and increased fluid balance may contribute to the development or worsening of AKI through increased central venous pressure and renal congestion. Fluid replacement strategies, including the type and dose of fluids administered, are important components of inpatient care and require adequate clinical expertise. Inappropriate fluid management can result in various complications, including metabolic acidosis, electrolyte imbalance, AKI or progression to chronic kidney disease (CKD), volume overload or dehydration, pulmonary injury, imbalance between proinflammatory and anti-inflammatory responses, impaired tissue perfusion, and tissue damage. These complications are associated with significant morbidity and mortality, as well as prolonged hospital stays.
Dari Imunostimulasi ke Imunomodulasi Kontekstual: Menata Ulang Pengembangan Imunomodulator Alami dari Ciplukan dan Propolis Raymond R. Tjandrawinata
MEDICINUS Vol. 39 No. 9 (2026): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/f29wyk52

Abstract

Natural products marketed to “boost immunity” are advancing faster than clinical science can define which immune responses are genuinely beneficial. A study of microparticulate Physalis angulata fruit extract and propolis shows biological signals in cells and animals but also reveals non-linear dose responses and a substantial translational gap between changes in leukocytes, splenic white pulp, and CD206 expression and meaningful protection in humans. This perspective proposes a shift from immune boosting to context-dependent immunomodulation. Development should proceed through three evidence layers: product identity and consistency, mechanism and therapeutic window, and clinically relevant benefit. Under this framework, an increased biomarker is not automatically interpreted as stronger immunity, and a multicomponent formulation should not be described as synergistic until the contribution and safety of its components are established.